Ítem
Acceso Abierto

Efecto de los dispositivos de emisión de microondas, radiofrecuencia no ablativa y ultrasonido microfocalizado en el tratamiento de la hiperhidrosis primaria revisión sistemática de la literatura

Mostrar el registro sencillo de la publicación
dc.contributor.advisorRincón, Diana
dc.contributor.advisorIbáñez Pinilla, Milcíades
dc.creatorParra Ulloa, Diana Catalina
dc.creatorCardona Olmos, Andrea
dc.creator.degreeEspecialista en Medicina Estética
dc.date.accessioned2016-08-31T13:59:09Z
dc.date.available2016-08-31T13:59:09Z
dc.date.created2016-06-01
dc.date.issued2016
dc.descriptionAntecedentes y objetivos: La hiperhidrosis primaria afecta el 2,8% de la población de Estados Unidos. Condición que impacta el desarrollo social de los individuos afectados, ocasionando fobia social. Existen opciones disponibles para el tratamiento de la hiperhidrosis incluyendo medicamentos tópico, sistémico, inyectable y quirúrgico. El objetivo de ésta revisión sistemática de la literatura es determinar la efectividad y seguridad de los dispositivos de emisión de microondas, radiofrecuencia no ablativa y sistema de ultrasonido microfocalizado para el tratamiento de la hiperhidrosis primaria. Materiales y métodos: Se realizó una revisión sistemática de la literatura de artículos obtenidos de bases de datos: Medline, Cochrane, Embase, Ovid y Scielo. Se incluyeron ensayos clínicos aleatorizados controlados, ensayos cuasiexperimentales desde el 2011; donde evaluaran el uso de estos dispositivos en el manejo de hiperhidrosis primaria. Resultados: Se seleccionaron 21 artículos en total. Se encontró que con los tres dispositivos se logra una reducción significativa a puntajes entre 1 y 2 de la escala de Severidad de la Hiperhidrosis; en 3 estudios se encontró mejoría en la calidad de vida; los eventos adversos fueron transitorios, siendo más frecuentes con el dispositivo de emisión de microondas. Conclusión: Primera revisión sistemática de la literatura sobre el efecto de estos tres dispositivos en el manejo de hiperhidrosis. Se espera aportar a la literatura existente una recomendación acerca de la efectividad y seguridad de estos dispositivos para que sea aplicado en los pacientes con diagnóstico de hiperhidrosis primaria.spa
dc.description.abstractMedical background and objectives: Hyperhidrosis primarily affects 2,8% of the American population. It is a condition that makes an impact on the social development of the individuals affected thus provoking a social phobia. A variety of options are available to treat Hyperhidrosis which include topical, systemic, injectable and surgical medication. The objective of the literature’s systematic revision is to determine the effectiveness and safety-assurance of the devices emitting microwaves, non-ablative radio frequencies and a micro focused ultrasound systems for the treatment of primary Hyperhidrosis. Materials and methods: A systematic revision of articles obtained from the database was carried out: Medline, Cochrane, Embase, Ovid and Scielo. Randomized controlled clinical articles were included and quasi-experimental essays dating back to 2011 where the use of these devices and the management of the primary Hyperhidrosis was evaluated.. Results: Total selected items were 21. It was found that with the three devices the marks between 1 and 2 within the Hyperhidrosis Severity Scale in 3 studies we found improvement in the quality of life; the adverse events are transitory. It is more frequent with microwave emitting device Conclusion: First systematic revision of the literature dealing with this three devices for the treatment of primary Hyperhidrosis. It is expected to provide to the existing literature recommendations regarding the effectiveness and assurance so that they can be applied on patients diagnosed with primary Hyperhidrosis.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_12358
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/12358
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentFacultad de Medicinaspa
dc.publisher.programEspecialización en Medicina Estética y laserspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto completo)spa
dc.rights.ccAtribución-CompartirIgual 2.5 Colombiaspa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-sa/2.5/co/
dc.source.bibliographicCitationCallejas M a., Grimalt R, Cladellas E. Actualización en hiperhidrosis. Actas Dermosifiliogr. 2010;101(2):110–8.
dc.source.bibliographicCitationKreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol. 2004;22(1):40–4.
dc.source.bibliographicCitationLakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: Anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013;5(5):1010–31.
dc.source.bibliographicCitationStrutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241–8.
dc.source.bibliographicCitationFujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: From questionnaire analysis. J Dermatol. 2013;40(11):886–90.
dc.source.bibliographicCitationHobart W, Swick L Brian. Treatment options for Hyperhidrosis. Am J Clin Dermatol 2011;12(5):285–95.
dc.source.bibliographicCitationLear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatologic Surg. 2007;33(SUPPL. 1):69–76.
dc.source.bibliographicCitationSolish N, Bertucci V, Dansereau A, Hong HCH, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatologic Surg. 2007;33(8):908–23.
dc.source.bibliographicCitationAngela D, Díaz M, Nataly , Cajas F. Manejo de la Hiperhidrosis primaria. Master en Medicina Estética y del Envejecimiento. Universitat Autonóma de Barcelona. 2012
dc.source.bibliographicCitationMoraites E, Vaughn OA, Hill S. Incidence and Prevalence of Hyperhidrosis. Dermatol Clin. Elsevier Inc; 2014;32(4):457–65.
dc.source.bibliographicCitationStashak A-B, Brewer JD. Management of hyperhidrosis. Clin Cosmet Investig Dermatol. 2014;285–99.
dc.source.bibliographicCitationCommons GW, Lim AF. Treatment of axillary hyperhidrosis/bromidrosis using vaser ultrasound. Aesthetic Plast Surg. 2009;33(3):312–23.
dc.source.bibliographicCitationCir RC, Original C. Evaluación de la satisfacción con el resultado clínico después de 10 años de simpatectomía videotoracoscópica bilateral para el manejo de la hiperhidrosis primaria. 2015;271–8.
dc.source.bibliographicCitationMaría S. Evaluación de la calidad de vida en pacientes con hiperhidrosis sometidos a simpaticectomía por toracoscopia . Clínica Cardiovascular. 2008;27(2):96–100.
dc.source.bibliographicCitationTu YR, Li X, Lin M, Lai FC, Li YP, Chen JF, et al. Epidemiological survey of primary palmar hyperhidrosis in adolescent in Fuzhou of People’s Republic of China. Eur J Cardio-thoracic Surg. 2007;31(4):737–9.
dc.source.bibliographicCitationLonsdale-Eccles a., Leonard N, Lawrence C. Axillary hyperhidrosis: Eccrine or apocrine? Clin Exp Dermatol. 2003;28(1):2–7.
dc.source.bibliographicCitationSchlereth T, Dieterich M, Birklein F. Hyperhidrosis--causes and treatment of enhanced sweating. Dtsch Arztebl Int. 2009;106(3):32–7.
dc.source.bibliographicCitationPinson PI, Olisova PO, Verkhogliad PI. Non-Invasive Short-Wave Guided Radiofrequency Device for Long-Term Sweat Reduction in Patients with Primary Axillary Hyperhidrosis : A Preliminary Study. :8–11.
dc.source.bibliographicCitationWolosker N, Krutman M, Kauffman P, Puech-leão P. Long-term results of oxybutynin use in treating facial hyperhidrosis. Anais Brasileiros de Dermatologia 2014:89 (6):912-6
dc.source.bibliographicCitationFernández DG, Oliva NP. Educación Médica Continuada Actualización en hiperhidrosis focal primaria Update on primary focal hyperhidrosis. Med Cutan Iber Lat Am 2012;40(6):173–80.
dc.source.bibliographicCitationHoorens I, Ongenae K. Primary focal hyperhidrosis: Current treatment options and a step-by-step approach. J Eur Acad Dermatology Venereol. 2012;26(1):1–8.
dc.source.bibliographicCitationGlaser DA, Coleman WP, Fan LK, Kaminer MS, Kilmer SL, Nossa R, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: The dermatologic reduction in underarm perspiration study. Dermatologic Surg. 2012;38(2):185–91.
dc.source.bibliographicCitationSolish N, Bertucci V, Dansereau A, Hong HCH, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatologic Surg. 2007;33(8):908–23.
dc.source.bibliographicCitationPignanelli S, Pulcrano G, Schiavone P, Iula VD, Catania MR. In vitro antimicrobial susceptibility of Mycoplasma hominis genital isolates. Indian J Dermatol Venereol Leprol. 2015;81(3):286–8.
dc.source.bibliographicCitationLee HH, Kim DW, Kim DW, Kim C. Efficacy of glycopyrrolate in primary hyperhidrosis patients. Korean J Pain. 2012;25(1):28–32.
dc.source.bibliographicCitationKim WO, Kil HK, Yoon KB, Yoon DM. Topical glycopyrrolate for patients with facial hyperhidrosis. Br J Dermatol. 2008;158(5):1094–7.
dc.source.bibliographicCitationSingh S, Davis H, Wilson P. Axillary hyperhidrosis: A review of the extent of the problem and treatment modalities. Surg [Internet]. Elsevier Ltd; 2015;3– 9.Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S1479666X15000359
dc.source.bibliographicCitationAbsar MS, Onwudike M. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Dermatol Surg. 2008;34(6):751–5.
dc.source.bibliographicCitationTrindade de Almeida AR, Montagner S. Botulinum Toxin for Axillary Hyperhidrosis. Dermatol Clin [Internet]. Elsevier Inc; 2014;32(4):495–504. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0733863514000801
dc.source.bibliographicCitationBaumann L, Anele S. Double-Blind, Randomized, Placebo-Controlled Pilot Study of the safety and efficacy of Myobloc (Botulinum toxin type B) for the treatment of palmar hyperhidrosis. 2000;(December 1989).
dc.source.bibliographicCitationHeckmann, M; Ceballos-Bauman, A.O Botulinum Toxin A for Axillary Hyperhidrosis. N. Engl. J. Med. 2001;344(7):488–93.
dc.source.bibliographicCitationBechara FG, Sand M, Hoffmann K, Boorboor P, Altmeyer P, Stuecker M. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Dermatologic Surg. 2008;34(8):1001–9.
dc.source.bibliographicCitationDumont P. Side Effects and Complications of Surgery for Hyperhidrosis. Thorac Surg Clin. 2008;18(2):193–207.
dc.source.bibliographicCitationGoldman A, Wollina U. Subdermal Nd-YAG laser for axillary hyperhidrosis. Dermatologic Surg. 2008;34(6):756–62.
dc.source.bibliographicCitationJohnson JE, O’Shaughnessy KF, Kim S. Microwave thermolysis of sweat glands. Lasers Surg Med. 2012;44(1):20–5.
dc.source.bibliographicCitationGlaser DA, Galperin T a. Local Procedural Approaches for Axillary Hyperhidrosis. Dermatol Clin. 2014
dc.source.bibliographicCitationHong HCH, Lupin M, O’Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatologic Surg. 2012;38(5):728–35.
dc.source.bibliographicCitationGlaser DA, Galperin T a. Managing Hyperhidrosis. Emerging Therapies. Dermatol Clin. 32 (2014) 549-553
dc.source.bibliographicCitationKim M, Shin JY, Lee J, Kim JY, Oh SH. Efficacy of Fractional Microneedle Radiofrequency Device in the Treatment of Primary Axillary Hyperhidrosis: A Pilot Study. Dermatology [Internet]. 2013;227(3):243–9. Disponible en: http://www.karger.com?doi=10.1159/000354602
dc.source.bibliographicCitationNestor MS, Park H. Safety and Efficacy of Micro-focused Ultrasound Plus Visualization for the Treatment of Axillary Hyperhidrosis. 2014;7(4):14–21.
dc.source.bibliographicCitationWells GA, Shea B, O’connell D, Peterson JEA, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
dc.source.bibliographicCitationTraductores CCI. Manual Cochrane de Revisiones Sistemáticas de Intervenciones, versión 5.1. 0. Man Cochrane Revis Sist Interv versión 510 [Internet]. 2012;(March):1–6 Disponible en: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Manual+Cochran e+de+revisiones+sistematicas+de+intervenciones#1
dc.source.bibliographicCitationCEBM Levels of Evidence Working Group. The oxford levels of evidence 2. [Internet]; 2009 [fecha de consulta 2 de marzo de 2016]. Disponible en: http://www.cebm.net/index.aspx?o=5653
dc.source.bibliographicCitationLupin M, Hong C.-H.H OK. A multi-center evaluation of the miradry system to treat subjects with axillary hyperhidrosis. Lasers Surg Med. 43 SUPPL.
dc.source.bibliographicCitationSuzanne Kilmer, William Coleman III, Larry Fan, Dee Anna Glaser, Michael Kaminer, Robert Nossa SS. A randomized, blinded clinical study of a microwave device for treatment of axillary hyperhidrosis. Am Soc Laser Med Surg. 2011;
dc.source.bibliographicCitationFatemi Naeini F, Pourazizi M, Abtahi-Naeini B, Nilforoushzadeh MA NJ. A novel option for treatment of primary axillary hyperhidrosis: Fractionated microneedle radiofrequency. J Postgr Med. 2015;61:(2):141–3.
dc.source.bibliographicCitationAbtahi-Naeini B, Naeini F, Saffaei A, Behfar S, Pourazizi M, Mirmohammadkhani M, et al. Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: Is it still effective after long-term follow-up? Indian J Dermatol [Internet]. 2016;61(2):234. Disponible en: http://www.eijd.org/text.asp?2016/61/2/234/177789
dc.source.bibliographicCitationCameron Rokhsar MJK. A retrospective anaylsis of the treatment of axillary hyperhidrosis with a novel microwave technology. Lasers Surg Med. 2013;45 SUPPL.
dc.source.bibliographicCitationMark Nestor HP. Evaluation of the efficacy and safety of micro-focused ultrasound for the treatment of axillary hyperhidrosis. Lasers Surg Med. 2012;44 SUPPL.
dc.source.bibliographicCitationFatemi Naeini F, Abtahi-Naeini B, Pourazizi M, Nilforoushzadeh MA, Mirmohammadkhani M. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study. Australas J Dermatol. 2014;(April 2014):279–84.
dc.source.bibliographicCitationNaeini FF, Saffaei A, Pourazizi M A-NB. Histopathological evidence of effifi cacy of microneedle radiofrequency for treatment of axillary hyperhidrosis. Indian J Dermatol Venereol Leprol. 2015;May-Jun;81.
dc.source.bibliographicCitationKim B, Kim B. Long-term Efficacy and Quality of Life Assessment for Treatment of Axillary Hyperhidrosis With a Microwave Device. 2014;(July):805–7.
dc.source.bibliographicCitationMark Lupin, H. Chih-ho Hong K, O’Shaughnessy. Long-term evaluation of microwave treatment for axillary hyperhidrosis. Lasers in Surgery and Medicine (2012) 44 SUPPL. 24 (6-7).
dc.source.bibliographicCitationIgor Pinson, Olga Olisova IV, Lepselter J. Long-term sweat reduction with noninvasive short wave radiofrequency device in patients with primary axillary hyperhidrosis: a preliminary study. Lasers in Surgery and Medicine (2014) 46 SUPPL. 25 (32).
dc.source.bibliographicCitationMark Lupin. Microwave-based treatment for primary axillary hyperhidrosis: Six months of follow-up. J Am Acad Dermatol. 2012;66:4 SUPPL.
dc.source.bibliographicCitationAbtahi-naeini B, Naeini FF, Adibi N, Pourazizi M. Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency. 2015;(July):6–8.
dc.source.bibliographicCitationMark Nestor M. Randomized, double-blind, controlled pilot study of the efficacy and safety of microfocused ultrasound for the treatment of axillary hyperhidrosis. Lasers Surg Med. 2013;45 SUPPL.
dc.source.bibliographicCitationLee S-J, Chang K-Y, Suh D-H, Song K-Y, Ryu HJ. The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study. J Cosmet Laser Ther [Internet]. 2013;15(5):255–9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23713761
dc.source.bibliographicCitationOtavio Macedo L, Matayoshi L, Matsumoto. The new ultrasound technology for hyperhidrosis treatment: Two case reports. Journal of the American Academy of Dermatology (2013) 68:4 SUPPL. 1
dc.source.bibliographicCitationSuh DH, Lee SJ, Kim K RH. Transient Median and Ulnar Neuropathy Associated with a Microwave Device for Treating Axillary Hyperhidrosis. Dermatol Surg. 2014 Apr;40(4):482-5
dc.source.bibliographicCitationScuderi S, Manoharan P, Lim D, Manoharan S. A survey of patient satisfaction with use of microwave device for axillary hyperhidrosis. Australas J Dermatol [Internet]. 2016;(October 2015):n/a – n/a. Disponible : http://doi.wiley.com/10.1111/ajd.12448
dc.source.bibliographicCitationTan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg. 2002;28(6):495–9.
dc.source.bibliographicCitationMicrowave-based treatment for primary axillary hyperhidrosis: Six months of followup. J Am Acad Dermatol [Internet]. 2012;66(4):AB215. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0190962211021293
dc.source.bibliographicCitationLee S-J, Chang K-Y, Suh D-H, Song K-Y, Ryu HJ. The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study. J Cosmet Laser Ther [Internet]. 2013;15(5):255–9. Disponible en: http://informahealthcare.com/doi/abs/10.3109/14764172.2013.807114
dc.source.bibliographicCitationNestor M. Park H. Randomized, double-blind, controlled pilot study of the efficacy and safety of micro-focused ultrasound for the treatment of axillary hyperhidrosis. Lasers Surg Med. 2013;19.
dc.source.bibliographicCitationOtavio C, Ltda M, Otavio C, Ltda M. The new ultrasound technology for hyperhidrosis treatment: Two case reports. J Am Acad Dermatol [Internet]. 2013;68(4):AB66. Disponible: http://linkinghub.elsevier.com/retrieve/pii/S0190962212015526
dc.source.bibliographicCitationVanderhelst E, De Keukeleire T, Verbanck S, Vincken W, Noppen M. Quality of Life and Patient Satisfaction After Video-Assisted Thoracic Sympathicolysis for Essential Hyperhidrosis: A Follow-Up of 138 Patients. J Laparoendosc Adv SurgTech. 2011;21(10):905–9.
dc.source.bibliographicCitationLowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol. 2007;56(4):604–11.
dc.source.bibliographicCitationKim M, Shin JY, Lee J, Kim JY, Oh SH. Efficacy of fractional microneedle radiofrequency device in the treatment of primary axillary hyperhidrosis: A pilot study. Dermatology. 2013;227(3):243–9.
dc.source.bibliographicCitationMalamud-Kessler Caroline, Estañol-Vidal Bruno, Ayala-Anaya Samuel, SentíesMadrid Horacio, Hernández-Camacho Marco. Physiology of vibration sense. Rev Mex Neuroci Mayo-Junio, 2014; 15(3): 163-170
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjecthiperhidrosisspa
dc.subjectdispositivo de microondasspa
dc.subjectradiofrecuencia no ablativaspa
dc.subjectultrasonido microfocalizadospa
dc.subjectefectividadspa
dc.subjectseguridadspa
dc.subject.ddcPromoción de salud
dc.subject.decsEstéticaspa
dc.subject.decsHiperhidrosisspa
dc.subject.decsMicroondasspa
dc.subject.decsEnfermedades de la pielspa
dc.subject.keywordHyperhidrosiseng
dc.subject.keywordmicrowave deviceseng
dc.subject.keywordnon-ablative radiofrequencyeng
dc.subject.keywordmicro-focused ultrasoundeng
dc.subject.keywordeffectivenesseng
dc.subject.keywordsafetyeng
dc.subject.lembEstética (Medicina)spa
dc.titleEfecto de los dispositivos de emisión de microondas, radiofrecuencia no ablativa y ultrasonido microfocalizado en el tratamiento de la hiperhidrosis primaria revisión sistemática de la literaturaspa
dc.typemasterThesiseng
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de gradospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
CardonaOlmos-Andrea-2016.pdf
Tamaño:
1.78 MB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Especialización en Medicina Estética y Laser